Updated:
Torrey Pines Investment
Torrey Pines Investment LLC is a specialty life-science investment company. It has a team of investment professionals with extensive experience in...
Torrey Pines Investment
Torrey Pines Investment LLC is a specialty life-science investment company. It has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. The firm has supported biopharma and diagnostics accelerators and invested in early development stage assets from pharma and biotech partners in CNS, oncology, and virology areas, bringing them to success through pharma partnering and M&A.
General information
Firm type
Private Equity
Year founded
2012
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Principals
Ronald Demuth
Founding President
Nikolay Savchuk
Managing Member
Eddie Rodriguez
Legal Counsel
Rouslan Michtchenko
Head of i2020 Accelerator
Michael G. Palfreyman
Head of Due Diligence
Simon Bennett
BD&L Advisor i2020 Accelerator
Christopher Rex
R&D Program Manager i2020 Accelerator
Frequently asked questions
Does Torrey Pines Investment participate in fund commitments or only direct deals?
Based on its stated early-stage focus, Torrey Pines Investment operates through direct equity investments. There is no public record of the firm making fund-of-funds commitments or participating as a limited partner in external venture capital vehicles.
Which sectors does Torrey Pines Investment prioritize?
The firm does not publish sector allocations. However, its San Diego location and early-stage posture suggest exposure to life sciences, technology, and software — sectors that dominate research-driven startup formation in the Southern California innovation economy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: